David M Schultz, MD | |
7400 France Ave S, Suite 100, Edina, MN 55435-4738 | |
(763) 537-6000 | |
(763) 537-6666 |
Full Name | David M Schultz |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 43 Years |
Location | 7400 France Ave S, Edina, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669481719 | NPI | - | NPPES |
715083100 | Medicaid | MN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 28811 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nura Pllc | 2769378942 | 24 |
News Archive
Statins are known to reduce the risk of further problems in patients of any age who have already suffered heart problems or stroke.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
With a rapidly ageing population, the number of people with dementia and other age-related disabilities is expected to soar by 2050.
Contrary to what was thought, sequences of DNA called enhancers - which control a gene's output - find their targets long before they are activated during embryonic development, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.
› Verified 3 days ago
Entity Name | Nura Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750316014 PECOS PAC ID: 2769378942 Enrollment ID: O20040322000281 |
News Archive
Statins are known to reduce the risk of further problems in patients of any age who have already suffered heart problems or stroke.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
With a rapidly ageing population, the number of people with dementia and other age-related disabilities is expected to soar by 2050.
Contrary to what was thought, sequences of DNA called enhancers - which control a gene's output - find their targets long before they are activated during embryonic development, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.
› Verified 3 days ago
Entity Name | Advanced Pain Management Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770506669 PECOS PAC ID: 1456257633 Enrollment ID: O20100714000576 |
News Archive
Statins are known to reduce the risk of further problems in patients of any age who have already suffered heart problems or stroke.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
With a rapidly ageing population, the number of people with dementia and other age-related disabilities is expected to soar by 2050.
Contrary to what was thought, sequences of DNA called enhancers - which control a gene's output - find their targets long before they are activated during embryonic development, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
David M Schultz, MD 2104 Northdale Blvd Nw, Suite 220, Minneapolis, MN 55433-3028 Ph: (763) 537-6000 | David M Schultz, MD 7400 France Ave S, Suite 100, Edina, MN 55435-4738 Ph: (763) 537-6000 |
News Archive
Statins are known to reduce the risk of further problems in patients of any age who have already suffered heart problems or stroke.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
With a rapidly ageing population, the number of people with dementia and other age-related disabilities is expected to soar by 2050.
Contrary to what was thought, sequences of DNA called enhancers - which control a gene's output - find their targets long before they are activated during embryonic development, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.
Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.
› Verified 3 days ago